What's New in Metastatic Breast Cancer?

Pittsburgh, PA US
May 2, 2020

The purpose of this seminar is to enhance the knowledge of the healthcare professional, breast cancer metastatic patient. and breast cancer survivor on making informed decisions about clinical trials, new therapies, new developments in preventing further metastases (antiangiogenesis) and information on emotional support and advocacy. 



Healthcare Professionals$45.00
General Attendees$15.00


Target Audience

08/Gyn's, PCP's. Nurse Practitioners. Physician Assistants, Nurses, other Health Care Professionals, Metastatic Breast Cancer Patients and Breast Cancer Survivors/Caregivers.

Learning Objectives

1.  Discuss the advantages of participating in a clinical trial and/or new interventional therapies.
2.  Identify modalities through palliative care in management of symptoms.
3.  Describe advances in the treatment of Brain Metastasis.
4.  Review the latest technology for clinical trial matching.
5.  Describe complimentary therapies. 

Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 Attendance
Course opens: 
Course expires: 
Event starts: 
05/02/2020 - 8:00am EDT
Event ends: 
05/02/2020 - 1:00pm EDT
Allegheny General Hospital-Magovern Auditorium
320 East North Aenue
Pittsburgh, PA 15222
United States

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Allegheny General Hospital and Glock Foundation.   Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Allegheny General Hospital designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 Attendance


Please login or register to take this course.